Journal Home
Search for

Volume 43, Issue 6, Pages 491-497 (December 2009)


View previous. 5 of 8 View next.

Evidence from knockout mice for distinct implications of neuropeptide-Y Y2 and Y4 receptors in the circadian control of locomotion, exploration, water and food intake

M.E. Edelsbrunnera, E. Painsippa, H. Herzogb, P. HolzeraCorresponding Author Informationemail address

Received 2 March 2009; accepted 31 August 2009. published online 25 September 2009.

Abstract 

Members of the neuropeptide-Y (NPY) family acting via Y2 and/or Y4 receptors have been proposed to participate in the control of ingestive behaviour and energy homeostasis. Since these processes vary between day and night, we explored the circadian patterns of locomotor, exploratory and ingestive behaviour in mice with disrupted genes for Y2 (Y2−/−) or Y4 (Y4−/−) receptors. To this end, the LabMaster system was used and its utility for the analysis of changes in circadian activity and ingestion caused by gene knockout evaluated. Female animals, aged 27weeks on average, were housed singly in cages fitted with sensors for water and food intake and two infrared frames for recording ambulation and rearing under a 12h light/dark cycle for 4days. Relative to WT animals, diurnal locomotion, exploration, drinking and feeding were reduced, whereas nocturnal locomotion was enhanced in Y2−/− mice. In contrast, Y4−/− mice moved more but ate and drank less during the photophase, while they ate more and explored less during the scotophase. Both Y2−/− and Y4−/− mice weighed more than WT mice. These findings attest to a differential role of Y2 and Y4 receptor signalling in the circadian control of behaviours that balance energy intake and energy expenditure. These phenotypic traits can be sensitively and continuously recorded by the LabMaster system.

a Research Unit of Translational Neurogastroenterology, Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Universitätsplatz 4, A-8010 Graz, Austria

b Neurobiology Research Program, Garvan Institute of Medical Research, Sydney, Australia

Corresponding Author InformationCorresponding author. Tel.: +43 316 3804500; fax: +43 316 3809645.

PII: S0143-4179(09)00090-0

doi:10.1016/j.npep.2009.08.007


View previous. 5 of 8 View next.